Adiponectin Testing Market Players:
- STRATEC SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Laboratory Corporation of America Holdings
- Bio-Rad Laboratories, Inc.
- Boster Biological Technology
- Thermo Fisher Scientific Inc.
- Eagle Biosciences, Inc.
- Merck KGaA
- ERBA Diagnostics, Inc.
- Zeus Scientific Inc.
- Trinity Biotech plc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of adiponectin testing is evaluated at USD 59.12 billion.
The global adiponectin testing market size was worth more than USD 55.24 billion in 2025 and is poised to witness a CAGR of over 7.8%, crossing USD 117.07 billion revenue by 2035.
North America adiponectin testing market will dominate over 41.6% share by 2035, driven by rising cases of cardiometabolic diseases, a growing obese population, and increased manufacturing of testing laboratories.
Key players in the market include STRATEC SE, Laboratory Corporation of America Holdings, Bio-Rad Laboratories, Inc., Boster Biological Technology, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc.
